Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries

Background. Several combinations of 2 or 3 direct-acting antivirals (DAAs) can cure hepatitis C virus (HCV) in the majority of treatment-naive patients. DAAs for HCV infection have similar mechanisms of action and chemical structures to antiretrovirals for human immunodeficiency virus (HIV) infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Andrew, Khoo, Saye, Fortunak, Joe, Simmons, Bryony, Ford, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952605/
https://www.ncbi.nlm.nih.gov/pubmed/24399087
http://dx.doi.org/10.1093/cid/ciu012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952605/
https://www.ncbi.nlm.nih.gov/pubmed/24399087
http://dx.doi.org/10.1093/cid/ciu012

Ejemplares similares